Subjects will be taken off their anti-hypertensive medications and undergo a 7-day washout period. Subjects that remain eligible after the washout period and subjects that do not require a washout (recently diagnosed or previously diagnosed and off treatment for > 1 week before starting the study) will receive placebo orally twice a day (bid) for a 3-day run-in period.